Your browser doesn't support javascript.
loading
Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Ueda, Hiroyuki; Kuno, Hideaki; Takahashi, Daisuke; Katsuma, Ai; Kimura, Ai; Nakashima, Akio; Kato, Junichiro; Momoki, Mamiko; Ohba, Rie; Dobashi, Nobuaki; Yamamoto, Izumi; Kawamura, Tetsuya; Miyazaki, Yoichi; Yokoo, Takashi.
Afiliación
  • Ueda H; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan. hi-ro@jikei.ac.jp.
  • Kuno H; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Takahashi D; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Katsuma A; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Kimura A; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Nakashima A; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Kato J; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Momoki M; Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Ohba R; Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Dobashi N; Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Yamamoto I; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Kawamura T; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Miyazaki Y; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
  • Yokoo T; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Nishi-shinbashi 3-25-8, Minato-ku, Tokyo, 105-8461, Japan.
CEN Case Rep ; 9(2): 165-172, 2020 05.
Article en En | MEDLINE | ID: mdl-31974826

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina D / Cadenas lambda de Inmunoglobulina / Bortezomib / Enfermedades Renales / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: CEN Case Rep Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina D / Cadenas lambda de Inmunoglobulina / Bortezomib / Enfermedades Renales / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: CEN Case Rep Año: 2020 Tipo del documento: Article País de afiliación: Japón